ClearPoint Neuro (CLPT) Cash from Financing Activities (2011 - 2026)

ClearPoint Neuro has reported Cash from Financing Activities for 14 years, with the latest figure at -$1.8 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 35.46% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.7 million (up 542.69% YoY) and the FY2025 annual result came in at $50.2 million, up 710.78% from the prior year.
• Cash from Financing Activities declined to -$1.8 million in Q1 2026 per CLPT's latest filing, from $19.6 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $32.0 million in Q2 2025 and troughed at -$10.1 million in Q3 2024.
• A 5-year average of $3.5 million and a median of $96000.0 in 2023 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 321160.0% in 2024, down 10956.04% in 2024.
• Over 5 years, Cash from Financing Activities stood at $222000.0 in 2022, then tumbled by 30.18% to $155000.0 in 2023, then plunged by 76.13% to $37000.0 in 2024, then surged by 52775.68% to $19.6 million in 2025, then sank by 109.43% to -$1.8 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$1.8 million, $19.6 million, and $32.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.